Amphetamines Panel (Qualitative), Oral Fluid (Saliva)

Method(s)

High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

Suggested CPT Code(s)

80324

80359

New York State Approval Status

Approved

Turnaround Time

7 days

Test Includes


1	Amphetamine		High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	2.5	Anorexigenic, Stimulant
2	Methamphetamine		High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	2.5	Stimulant
3	MDA	3,4-Methylenedioxyamphetamine; Adam; MDMA Metabolite	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	2.5	Stimulant
4	MDMA	3,4-Methylenedioxymethamphetamine; Ecstasy	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	2.5	Stimulant

Test Also Known As

Adderall; Amfetamine; Desoxyn® Dextroamphetamine; Ecstasy; Levoamphetamine; Meth; Molly

Compliance Statement

This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.

Sample Type

Oral Fluid (Saliva)

Requested Volume

2 mL

Minimum Volume

0.7 mL

Special Handling

Collect oral fluid according to manufacturer's directions. Pour-off containers are acceptable. DO NOT FREEZE.

Sample Container

Oral Fluid collection device

Additional Collection Instructions

Transport Temperature

Refrigerated

Light Protection

Not Required

Rejection Criteria

None

Rejection criteria pertain to clinical sample submissions only.

Stability

Room Temperature: 30 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): Undetermined

The stability information provided is for the Quantisal(TM) collection device with the pad inside of the device. For other devices, follow manufacturer's recommendations.

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.